Submission Details
| 510(k) Number | K240426 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 13, 2024 |
| Decision Date | May 14, 2024 |
| Days to Decision | 91 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K240426 is an FDA 510(k) clearance for the Aventus Clot Management System, a Apparatus, Autotransfusion (Class II — Special Controls, product code CAC), submitted by Inquis Medical (Menlo Park, US). The FDA issued a Cleared decision on May 14, 2024, 91 days after receiving the submission on February 13, 2024. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 868.5830.
| 510(k) Number | K240426 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 13, 2024 |
| Decision Date | May 14, 2024 |
| Days to Decision | 91 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | CAC — Apparatus, Autotransfusion |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5830 |